Activation of B1a cells in peritoneal cavity by T cell-independent antigen expressed on polymeric micelle

Journal of Pharmaceutical Sciences

Volumn 104, Issue 5, 2015, Pages 1839-1847

  Kim, Cheol Joo ^a   Hara, Eri ^b   Shimizu, Akira ^b   Sugai, Manabu ^b   Kimura, Shunsaku ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clearance; Immune response; Immunology; Micelle; Nanoparticles; Polymeric drug carrier

Indexed keywords

DEPSIPEPTIDE; IMMUNOGLOBULIN M; POLYLACTIC ACID; POLYSARCOSINE BLOCK POLYLACTIC ACID; SARCOSINE; UNCLASSIFIED DRUG; CD27 ANTIGEN; MICELLE; POLYMER;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SECRETING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CATALYST; CELL COUNT; CELL MIGRATION; CELL SELECTION; CELL TRANSFER; CONTROLLED STUDY; IMMUNE RESPONSE; LACTOSOME; LIGHT SCATTERING; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MICELLE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM CELL; POLYMERIZATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD27; B-LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICELLES; PERITONEAL CAVITY; POLYMERS; T-LYMPHOCYTES;

EID: 84926676535     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24397     Document Type: Article

References (29)

1. Mosier DE, Subbarao B. 1982. Thymus-independent antigens - Complexity of lymphocyte-B activation revealed. Immunol Today 3:217-222.
2. Obukhanych TV, Nussenzweig MC. 2006. T-independent type II immune responses generate memory B cells. J Exp Med 203:305-310.
3. Hess C, Winkler A, Lorenz AK, Holecska V, Blanchard V, Eiglmeier S, Schoen AL, Bitterling J, Stoehr AD, Petzold D, Schommartz T, Mertes MMM, Schoen CT, Tiburzy B, Herrmann A, Kohl J, Manz RA, Madaio MP, Berger M, Wardemann H, Ehlers M. 2013. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J Clin Invest 123:3788-3796.
4. Cerutti A, Cols M, Puga I. 2013. Marginal zone B cells: Virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118-132.
5. Ha SA, Tsuji M, Suzuki K, Meek B, Yasuda N, Kaisho T, Fagarasan S. 2006. Regulation of b1 cell migration by signals through Toll-like receptors. J Exp Med 203:2541-2550.
6. Hara E, Makino A, Kurihara K, Yamamoto F, Ozeki E, Kimura S. 2012. Pharmacokinetic change of nanoparticulate formulation "Lactosome"on multiple administrations. Int Immunopharmacol 14:261-266.
7. Fang J, Nakamura H, Maeda H. 2011. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136-151.
8. Maeda H. 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. In Advances in enzyme regulation; Weber G, Ed. Vol. 41. Oxford, UK: Pergamon-Elsevier Science Ltd., pp 189-207.
9. Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer-chemotherapy - Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387-6392.
10. Makino A, Yamahara R, Ozeki E, Kimura S. 2007. Preparation of novel polymer assemblies, "Lactosome", composed of poly(L-lactic acid) and poly(sarcosine). Chem Lett 36:1220-1221.
11. Makino A, Kizaka-Kondoh S, Yamahara R, Hara I, Kanzaki T, Ozeki E, Hiraoka M, Kimura S. 2009. Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Biomaterials 30:5156-5160.
12. Yamamoto F, Yamahara R, Makino A, Kurihara K, Tsukada H, Hara E, Hara I, Kizaka-Kondoh S, Ohkubo Y, Ozeki E, Kimura S. 2013. Radiosynthesis and initial evaluation of F-18 labeled nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Nucl Med Biol 40:387-394.
13. Hara E, Makino A, Kurihara K, Ueda M, Hara I, Kawabe T, Yamamoto F, Ozeki E, Togashi K, Kimura S. 2013. Radionuclide therapy using nanoparticle of I-131-lactosome in combination with percutaneous ethanol injection therapy. J Nanopart Res 15:2131.
14. Funayama T, Sakane M, Abe T, Hara I, Ozeki E, Ochiai N. 2012. Intraoperative near-infrared fluorescence imaging with novel indocyanine green-loaded nanocarrier for spinal metastasis: A preliminary animal study. Open Biomed Eng J 6:80-84.
15. Eschenbrenner M, Jorns MS. 1999. Cloning and mapping of the cDNA for human sarcosine dehydrogenase, a flavoenzyme defective in patients with sarcosinemia. Genomics 59:300-308.
16. Nampoothiri KM, Nair NR, John RP. 2010. An overview of the recent developments in polylactide (PLA) research. Bioresour Technol 101:8493-8501.
17. Abu Lila AS, Kiwada H, Ishida T. 2013. The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage. J Control Release 172:38-47.
18. Dams ETM, Laverman P, Oyen WJG, Storm G, Scherphof GL, Van der Meer JWM, Corstens FHM, Boerman OC. 2000. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 292:1071-1079.
19. Ishida T, Maeda R, Ichihara M, Irimura K, Kiwada H. 2003. Accelerated clearance of pegylated liposomes in rats after repeated injections. J Control Release 88:35-42.
20. Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N. 2008. Particle size-dependent triggering of accelerated blood clearance phenomenon. Int J Pharm 362:197-200.
21. Koide H, Asai T, Hatanaka K, Akai S, Ishii T, Kenjo E, Ishida T, Kiwada H, Tsukada H, Oku N. 2010. T cell-independent B cell response is responsible for abc phenomenon induced by repeated injection of PEGylated liposomes. Int J Pharm 392:218-223.
22. Abu Lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H. 2013. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin m production from murine splenic B cells stimulated by PEGylated liposome. Biol Pharm Bull 36:1842-1848.
23. Shimizu T, Ishida T, Kiwada H. 2013. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon. Immunobiology 218:725-732.
24. Hara E, Makino A, Kurihara K, Sugai M, Shimizu A, Hara I, Ozeki E, Kimura S. 2013. Evasion from accelerated blood clearance of nanocarrier named as "Lactosome" induced by excessive administration of lactosome. Biochim Biophys Acta 1830:4046-4052.
25. Hara E, Ueda M, Akira M, Hara I, Ozeki E, Kimura S. 2014. Factors influencing in vivo disposition of polymeric micelles on multiple administrations. ACS Med Chem Lett 5:873-877.
26. Hara E, Ueda M, Kim CJ, Akira M, Hara I, Ozeki E, Kimura S. 2014. Suppressive immune response of poly(sarcosine) chains in peptidenanosheets in contrast to polymeric micelles. J Pept Sci 20:570-577.
27. Berland R, Wortis HH. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20:253-300.
28. Kuroda E, Yamashita U. 2003. Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol 170:757-764.
29. Foote JB, Mahmoud TI, Vale AM, Kearney JF. 2012. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells. J Immunol 188:57-67.